In a statement to the Hong Kong Stock Exchange on Monday, CanSino announced that China's Central Military Commission had given the vaccine a "military specially-needed drug approval" on June 25. The special permission will last for one year and will only apply to military personnel.

 

Read more: https://www1.hkexnews.hk/listedco/listconews/sehk/2020/0629/2020062900123.pdf